Arecibo, PR

Arecibo, PR 00612

0 studies enrolling now · 2 studies all time

What they study most

Diabetic Macular Edema (DME), Neovascular Age-related Macular Degeneration (NVAMD)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• A 2-part Study Consisting of Multiple Ascending Dose (MAD) Safety Study, and a Dose-finding Masked Study to Assess the Safety and Efficacy of Intravitreal (IVT) EYE103 in Patients With Diabetic Macular Edema (DME) or Neovascular Age-related Macular Degeneration (NVAMD) — Completed